Osimertinib, third-generation EGFR-TKI, treats NSCLC with EGFR mutations, including EGFR Ex19Del or EGFR L858R, targets central nervous system metastasis, irreversible inhibition,
Sale!
Lucius
Replica: Osimertinib 3rd Gen EGFR-TKI for NSCLC
Original price was: $605.00.$446.00Current price is: $446.00.
Osimertinib, third-generation EGFR-TKI, treats NSCLC with EGFR mutations, including EGFR Ex19Del or EGFR L858R, targets central nervous system metastasis, irreversible inhibition,